1.5 Abstract in rivista

1.5 Abstract in rivista: [1475] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 401 a 420 di 1.475

‘MEMORIAL’ PLUS AMIFOSTINE EFFICACY AND FEASIBILITY IN AN ELDERLY COHORT OF 149 AML PATIENTS

2014-01-01 Capelli, D; Chiarucci, M; Saraceni, F; Poloni, Antonella; Mancini, G; Trappolini, S; Offidani, M; Rupoli, S; Montanari, M; Scortechini, Ar; Gini, G; Scortechini, I; Discepoli, G; Leoni, P; Olivieri, A.

LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE

2014-01-01 Capelli, D; Attolico, I; Saraceni, Francesco; Mancini, Stefania; Scortechini, Ar; Poloni, Antonella; Bartocci, C; Viola, N; Pascale, S; Nuccorini, R; Chiarucci, Martina; Serrani, F; Pizzuti, M; Leoni, Pietro; Olivieri, Attilio

HUMAN MATURE BONE MARROW ADIPOCYTES MANTAIN THE SURVIVAL AND DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS

2014-01-01 Maurizi, G; 1 Mattiucci, D; 1 Mancini, S; Olivieri, Attilio; Cinti, Saverio; 2 Leoni, P; Poloni, Antonella

OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME

2014-01-01 Mattiucci, Domenico; Maurizi, G; Amatori, S; Costantini, B; Mariani, M; Mancini, Stefania; Fanelli, M; Olivieri, Attilio; Leoni, Pietro; Poloni, Antonella

CLINICAL BENEFIT OF LENALIDOMIDE TREATMENT FOR LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROME WITH DEL(5Q) BEFORE TRANSFUSION DEPENDENCE

2014-01-01 E., Oliva1; *, ; M., Lauseker2; M. A., Aloe Spiriti3; Poloni, Antonella; A., Cortelezzi5; G., Palumbo6; E., Balleari7; G., Sanpaolo8; A., Volpe9; A., Ricco10; F., Ronco1; C., Alati1; I., Santacaterina1; A., Kündgen11; U., Germing11; R., Latagliata12

MOLECULAR PREDICTORS OF RESPONSE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA

2014-01-01 Rossi, A; 1 Valencia, A; 1 Abdel Wahab, O; 2 Figueroa, Me; 3 Tingting, Q; 3 Meldi, K; 3 Buchi, F; 1 Masala, E; 1 Sanna, A; 1 Allione, B; 4 Lunghi, M; Poloni, Antonella; 6 Angelucci, E; 7 Finelli, C; 8 Levis, A; 9 Santini, V1

IRON-CHELATING THERAPY WITH DEFERASIROX IN HIGHER RISK MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE, MULTICENTER, ITALIAN STUDY

2014-01-01 P., Musto1; *, ; L., Maurillo2; V., Simeon3; Poloni, Antonella; C., Finelli5; C., Clissa5; E., Balleari6; A., Ricco7; Am, D’Arco8; A., Cortelezzi9; G., Tarantini10; O., Villani11; G., Mansueto11; C., Criscuolo11; M., Breccia12; P., Niscola13; A., Sanna14; F., Autore15; Mt, Voso15; S., Fenu16; A., Venditti2; V., Santini14; A., Levis17

TARGETED SEQUENCING ANALYSIS OF COMMONLY MUTATED GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA USING NGS: IMPACT AND CLINICAL IMPLICATIONS

2015-01-01 Valencia, A; Abdel Wahab, O; Buchi, F; Masala, E; Sanna, A; Gozzini, A; Figueroa, Me; Contini, E; Torricelli, F; B., Allione B; Lunghi, M; Onida, F; Poloni, Antonella; Angelucci, E; Finelli, C; Levis, A; Gioia, D; Bosi, A; Santini, V.

COMBINATION OF LENALIDOMIDE AND RITUXIMAB AS SALVAGE THERAPY IN ELDERLY PATIENTS AFFECTED BY DIFFUSE LARGE B CELLS LYMPHOMA RELAPSED AND REFRACTORY i

2015-01-01 G., Gini; C., Bocci; M., Sampaolo; S., Trappolini; S., Cacciagiù; J., Olivieri; Olivieri, Attilio; M., Offidani; S., Rupoli; Poloni, Antonella; A. R., Scortechini; D., Capelli; M., Montanari; I., Scortechini; Leoni, Pietro

MONITORING STRATEGY OF ANTHRACYCLINES CARDOTOXICITIES BY BIOMARKERS AND ECOCARDIOGRAPHY IN 104 PRESPECTIVES PATIENTS AFFECTED BY LYMPHOMA

2015-01-01 G. Gini, J. Olivieri; C., Bocci; S., Cacciagiù; M., Sampaolo; S., Trappolini; Olivieri, Attilio; M., Offidani; S., Rupoli; Poloni, Antonella; D., Capelli; M., Montanari; I., Scortechini; G. P., Perna; Leoni, Pietro

TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE

2015-01-01 Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; Mancini, Stefania; Olivieri, Attilio; Leoni, Pietro

LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON 5Q- MYELODYSPLASTIC SYNDROMES

2015-01-01 Galimberti, S; Ciabatti E: Rousseau M: Guerrini, F; Cecconi, N; Cervetti, G; Musto, P; La Rocca, F; Cilloni, D; Gaidano, V; Petrini, I; Poloni, Antonella; Palumbo, Ga; Grassi, S.

MGA GUIDED INTENSIVE INDUCTION WITH HIGH DOSE CYTARABINE PLUS IDARUBICIN IN 149 AML ELDERLY PATIENTS

2015-01-01 D., Capelli; F., Saraceni; M., Chiarucci; Poloni, Antonella; G., Discepoli; Leoni, Pietro; Olivieri, Attilio

LOW RPS14 EXPRESSION IN THE NON 5Q- MYELODYSPLASTIC SYNDROMES

2015-01-01 S., Grassi1; E., Ciabatti1; M., Rousseau2; F., Guerrini1; N., Cecconi1; G., Cervetti1; P., Musto3; F., La Rocca4; D., Cilloni5; V., Gaidano5; I., Petrini6; Poloni, Antonella; G. A., Palumbo8; S., Galimberti1; *,

QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBOCONTROLLED PROSPECTIVE TRIAL

2015-01-01 E. N., Oliva1; * V., Santini2; C., Alati1; G., Sanpaolo3; Poloni, Antonella; A., Molteni5; F., Ronco1; G., Palumbo6; A., Marino1; S., Impera7; E., Balleari8; P., Salutari9; P., Cufari1; I., Santacaterina1; P., Avanzini10; P., Niscola11; A. M., Liberati12; A., Ricco13; F., Morabito14; A., Cortelezzi15; L., Fianchi16; F., Buccisano17; P., Fenaux18; O., Beyne Rauzy19; F., Rodeghiero20; F., Salvi21; R., Latagliata22

IN VITRO CULTURE OF BM CELLS OF MDS PATIENTS AND CYTC POLYMORPHISMS CAN PREDICT THE IN VIVO HEMATOLOGICAL RESPONSE OBSERVED DURING IRON CHELATION THERAPY WITH DEFERASIROX

2015-01-01 Cilloni, Daniela; Podestà, Marina; Cossu, C.; Calabrese, C.; Sabatini, F.; Del Corso, L.; Niscola, Pasquale; Crugnola, M.; Poloni, Antonella; Voso, Maria Teresa; Pelizzari, Susanna Fenu Anna Maria; Salvi, Flavia; Gioia, Daniela; Masiera, Elisa; Balleari, Enrico; Saglio, Giuseppe; Frassoni, Francesco

MECHANISM OF RESISTANCE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA

2014-01-01 Rossi A, Valencia A; Meldi K, Buchi F; Poloni, Antonella

Prognostic factors of response to erytropoiesis stimulating agents (ESA) Treatment in non RBC transfusion dependent lower risk MDS. Preliminary results of a french and italian study (on behalf of the GFM and FISM)

2012-01-01 Park, S; Zini, G; Andrieu, V; Levis, A; Gioia, D; Duchayna, E; Poloni, Antonella; Balleari, E; Calabrese, M; Sudaka, I; Siguret, V; Guesnu, M; Kosmider, O; Fontenay, M; Sanna, A; Lemaire, P; Beyne Rauzy, O; Ades, L; Legros, L; Danise, P; Musto, P; Fenaux, P; Dreyfus, F; Santini, V.

Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS)

2012-01-01 Oliva, En; Santini, V; Zini, G; Palumbo, G; Poloni, Antonella; Cortelezzi, A; Voso, Mt; Molteni, A; Sanpaolo, G; Marino, A; Rodà, F; Alati, C; Ronco, F; Di Raimondo, F; Leoni, Pietro; Alimena, G; Finotto, S; Latagliata, R; Nobile, F.

High predictive value of the revised international prognostic scoring system (IPSS-R): an external analysis of 646 patients from a multiregional italian MDS registry

2012-01-01 Messa, E; Gioia, D; Evangelista, A; Allione, B; Angelucci, E; Balleari, E; Calabrese, M; Catarini, M; Centurioni, R; Danise, P; Del Corso, L; Masiera, E; Musto, P; Pane, F; Poloni, Antonella; Sanna, A; Tassara, R; Ciccone, G; Levis, A; Saglio, G; Santini, V.

Titolo	Data di pubblicazione	Autore(i)
‘MEMORIAL’ PLUS AMIFOSTINE EFFICACY AND FEASIBILITY IN AN ELDERLY COHORT OF 149 AML PATIENTS	1-gen-2014	Capelli, D; Chiarucci, M; Saraceni, F; Poloni, Antonella; Mancini, G; Trappolini, S; Offidani, M; Rupoli, S; Montanari, M; Scortechini, Ar; Gini, G; Scortechini, I; Discepoli, G; Leoni, P; Olivieri, A.
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE	1-gen-2014	Capelli, D; Attolico, I; Saraceni, Francesco; Mancini, Stefania; Scortechini, Ar; Poloni, Antonella; Bartocci, C; Viola, N; Pascale, S; Nuccorini, R; Chiarucci, Martina; Serrani, F; Pizzuti, M; Leoni, Pietro; Olivieri, Attilio
HUMAN MATURE BONE MARROW ADIPOCYTES MANTAIN THE SURVIVAL AND DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS	1-gen-2014	Maurizi, G; 1 Mattiucci, D; 1 Mancini, S; Olivieri, Attilio; Cinti, Saverio; 2 Leoni, P; Poloni, Antonella
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME	1-gen-2014	Mattiucci, Domenico; Maurizi, G; Amatori, S; Costantini, B; Mariani, M; Mancini, Stefania; Fanelli, M; Olivieri, Attilio; Leoni, Pietro; Poloni, Antonella
CLINICAL BENEFIT OF LENALIDOMIDE TREATMENT FOR LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROME WITH DEL(5Q) BEFORE TRANSFUSION DEPENDENCE	1-gen-2014	E., Oliva1; *, ; M., Lauseker2; M. A., Aloe Spiriti3; Poloni, Antonella; A., Cortelezzi5; G., Palumbo6; E., Balleari7; G., Sanpaolo8; A., Volpe9; A., Ricco10; F., Ronco1; C., Alati1; I., Santacaterina1; A., Kündgen11; U., Germing11; R., Latagliata12
MOLECULAR PREDICTORS OF RESPONSE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA	1-gen-2014	Rossi, A; 1 Valencia, A; 1 Abdel Wahab, O; 2 Figueroa, Me; 3 Tingting, Q; 3 Meldi, K; 3 Buchi, F; 1 Masala, E; 1 Sanna, A; 1 Allione, B; 4 Lunghi, M; Poloni, Antonella; 6 Angelucci, E; 7 Finelli, C; 8 Levis, A; 9 Santini, V1
IRON-CHELATING THERAPY WITH DEFERASIROX IN HIGHER RISK MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE, MULTICENTER, ITALIAN STUDY	1-gen-2014	P., Musto1; *, ; L., Maurillo2; V., Simeon3; Poloni, Antonella; C., Finelli5; C., Clissa5; E., Balleari6; A., Ricco7; Am, D’Arco8; A., Cortelezzi9; G., Tarantini10; O., Villani11; G., Mansueto11; C., Criscuolo11; M., Breccia12; P., Niscola13; A., Sanna14; F., Autore15; Mt, Voso15; S., Fenu16; A., Venditti2; V., Santini14; A., Levis17
TARGETED SEQUENCING ANALYSIS OF COMMONLY MUTATED GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA USING NGS: IMPACT AND CLINICAL IMPLICATIONS	1-gen-2015	Valencia, A; Abdel Wahab, O; Buchi, F; Masala, E; Sanna, A; Gozzini, A; Figueroa, Me; Contini, E; Torricelli, F; B., Allione B; Lunghi, M; Onida, F; Poloni, Antonella; Angelucci, E; Finelli, C; Levis, A; Gioia, D; Bosi, A; Santini, V.
COMBINATION OF LENALIDOMIDE AND RITUXIMAB AS SALVAGE THERAPY IN ELDERLY PATIENTS AFFECTED BY DIFFUSE LARGE B CELLS LYMPHOMA RELAPSED AND REFRACTORY i	1-gen-2015	G., Gini; C., Bocci; M., Sampaolo; S., Trappolini; S., Cacciagiù; J., Olivieri; Olivieri, Attilio; M., Offidani; S., Rupoli; Poloni, Antonella; A. R., Scortechini; D., Capelli; M., Montanari; I., Scortechini; Leoni, Pietro
MONITORING STRATEGY OF ANTHRACYCLINES CARDOTOXICITIES BY BIOMARKERS AND ECOCARDIOGRAPHY IN 104 PRESPECTIVES PATIENTS AFFECTED BY LYMPHOMA	1-gen-2015	G. Gini, J. Olivieri; C., Bocci; S., Cacciagiù; M., Sampaolo; S., Trappolini; Olivieri, Attilio; M., Offidani; S., Rupoli; Poloni, Antonella; D., Capelli; M., Montanari; I., Scortechini; G. P., Perna; Leoni, Pietro
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE	1-gen-2015	Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; Mancini, Stefania; Olivieri, Attilio; Leoni, Pietro
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON 5Q- MYELODYSPLASTIC SYNDROMES	1-gen-2015	Galimberti, S; Ciabatti E: Rousseau M: Guerrini, F; Cecconi, N; Cervetti, G; Musto, P; La Rocca, F; Cilloni, D; Gaidano, V; Petrini, I; Poloni, Antonella; Palumbo, Ga; Grassi, S.
MGA GUIDED INTENSIVE INDUCTION WITH HIGH DOSE CYTARABINE PLUS IDARUBICIN IN 149 AML ELDERLY PATIENTS	1-gen-2015	D., Capelli; F., Saraceni; M., Chiarucci; Poloni, Antonella; G., Discepoli; Leoni, Pietro; Olivieri, Attilio
LOW RPS14 EXPRESSION IN THE NON 5Q- MYELODYSPLASTIC SYNDROMES	1-gen-2015	S., Grassi1; E., Ciabatti1; M., Rousseau2; F., Guerrini1; N., Cecconi1; G., Cervetti1; P., Musto3; F., La Rocca4; D., Cilloni5; V., Gaidano5; I., Petrini6; Poloni, Antonella; G. A., Palumbo8; S., Galimberti1; *,
QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBOCONTROLLED PROSPECTIVE TRIAL	1-gen-2015	E. N., Oliva1; * V., Santini2; C., Alati1; G., Sanpaolo3; Poloni, Antonella; A., Molteni5; F., Ronco1; G., Palumbo6; A., Marino1; S., Impera7; E., Balleari8; P., Salutari9; P., Cufari1; I., Santacaterina1; P., Avanzini10; P., Niscola11; A. M., Liberati12; A., Ricco13; F., Morabito14; A., Cortelezzi15; L., Fianchi16; F., Buccisano17; P., Fenaux18; O., Beyne Rauzy19; F., Rodeghiero20; F., Salvi21; R., Latagliata22
IN VITRO CULTURE OF BM CELLS OF MDS PATIENTS AND CYTC POLYMORPHISMS CAN PREDICT THE IN VIVO HEMATOLOGICAL RESPONSE OBSERVED DURING IRON CHELATION THERAPY WITH DEFERASIROX	1-gen-2015	Cilloni, Daniela; Podestà, Marina; Cossu, C.; Calabrese, C.; Sabatini, F.; Del Corso, L.; Niscola, Pasquale; Crugnola, M.; Poloni, Antonella; Voso, Maria Teresa; Pelizzari, Susanna Fenu Anna Maria; Salvi, Flavia; Gioia, Daniela; Masiera, Elisa; Balleari, Enrico; Saglio, Giuseppe; Frassoni, Francesco
MECHANISM OF RESISTANCE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA	1-gen-2014	Rossi A, Valencia A; Meldi K, Buchi F; Poloni, Antonella
Prognostic factors of response to erytropoiesis stimulating agents (ESA) Treatment in non RBC transfusion dependent lower risk MDS. Preliminary results of a french and italian study (on behalf of the GFM and FISM)	1-gen-2012	Park, S; Zini, G; Andrieu, V; Levis, A; Gioia, D; Duchayna, E; Poloni, Antonella; Balleari, E; Calabrese, M; Sudaka, I; Siguret, V; Guesnu, M; Kosmider, O; Fontenay, M; Sanna, A; Lemaire, P; Beyne Rauzy, O; Ades, L; Legros, L; Danise, P; Musto, P; Fenaux, P; Dreyfus, F; Santini, V.
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS)	1-gen-2012	Oliva, En; Santini, V; Zini, G; Palumbo, G; Poloni, Antonella; Cortelezzi, A; Voso, Mt; Molteni, A; Sanpaolo, G; Marino, A; Rodà, F; Alati, C; Ronco, F; Di Raimondo, F; Leoni, Pietro; Alimena, G; Finotto, S; Latagliata, R; Nobile, F.
High predictive value of the revised international prognostic scoring system (IPSS-R): an external analysis of 646 patients from a multiregional italian MDS registry	1-gen-2012	Messa, E; Gioia, D; Evangelista, A; Allione, B; Angelucci, E; Balleari, E; Calabrese, M; Catarini, M; Centurioni, R; Danise, P; Del Corso, L; Masiera, E; Musto, P; Pane, F; Poloni, Antonella; Sanna, A; Tassara, R; Ciccone, G; Levis, A; Saglio, G; Santini, V.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 401 a 420 di 1.475

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext1473
open1
reserved1